1 year return (CAGR)
52.68%
Monopar Therapeutics Inc Exchange (NASDAQ, USD)
MNPR
96.63
+0.91 (+0.95%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
217.29%
5 year return (CAGR)
32.79%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
648.60M
Price/Sales
-
Ent value
599.96M
Price/Book
4.96
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
26.33%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 96.09 |
| Daily high | 97.25 |
| Daily low | 94.00 |
| Daily Volume | 136K |
| All-time high | 135.00 |
| 1y analyst estimate | 126.31 |
| Beta | 1.51 |
| EPS (TTM) | -2.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MNPR | S&P500 | |
| Current price drop from All-time high | -28.42% | -0.58% |
| Highest price drop | -98.93% | -56.47% |
| Date of highest drop | 20 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -77.91% | -10.68% |
| Avg time to new high | 848 days | 12 days |
| Max time to new high | 1696 days | 1805 days |
News
